Congressional Briefing Helps Debunk "Windfall" Argument of Device Tax
Thursday, September 13, 2012
New research shows that despite providing near-universal health care
coverage in the state of Massachusetts, the overwhelming percentage of
medical device companies saw no increases in utilization, and in turn
profits. This new data helps debunk the main argument for supporters of
the 2.3 % medical device excise tax.
The report was detailed in a Congressional briefing hosted by CONNECT.
Alex Lukianov, MDMA Board member and Chairman & Chief Executive
Officer of NuVasive, Inc, and Matthew Dolan, Senior Research Analyst at
ROTH Capital Partners LLC, detailed the challenges that face the med
tech ecosystem at the briefing, and why repealing the medical device tax
is so important.
The event was an opportunity for Capitol Hill staff and Washington
media to learn more about the industry, and get updates about the